LIVE QUOTE
Humana Inc. HUM
Healthcare · Medical - Healthcare Plans · NYSE
$305.12
Market Cap$28.0B
P/E Ratio12.0
Dividend Yield0.60%
Beta0.68
Employees65,680

Investment Thesis

. Any significant market corrections or adjustments in regulatory frameworks may warrant a reassessment of the position.

Competitive Moat

, characterized primarily by regulatory advantages and scale economies. The company's established relationships with the Centers for Medicare and Medicaid Services create high barriers to entry for new competitors, while its extensive network of healthcare providers enhances customer retention through network effects. This competitive advantage is likely to persist for the next 5-10 years, although emerging telehealth providers and managed care organizations could pose competitive threats, necessitating continued innovation and service enhancement.

Growth Engine

Future revenue growth for Humana will stem from its increasing membership in Medicare Advantage plans, which has been a major driver of organic growth. The total addressable market for Medicare beneficiaries exceeds 60 million individuals, providing a substantial runway for expansion. Additionally, Humana's foray into integrated healthcare services, including home health and pharmacy solutions, is expected to bolster revenue streams and solidify its market position. The company is gaining market share in several key regions, indicating strong competitive positioning.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research HUM
Robinhood
$0 commission trades
Trade HUM
Webull
Extended-hours, options, charts
Trade HUM
TradingView
Advanced charts & screeners
Chart HUM
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-05-27, HUM's P/E ratio is not available, which may indicate that the stock is not currently profitable or that it is not a suitable comparison for valuation. Investors should consider the company's growth potential and market position within the healthcare sector before making a decision.
Humana Inc. does not currently pay a dividend, which may be a consideration for income-focused investors.
HUM operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry.
The market cap for Humana Inc. is not available; however, given its business operations and membership size, it is likely categorized as a large-cap or mega-cap company.
Humana Inc.'s competitors include companies such as UnitedHealth Group and Anthem, which also operate in the healthcare plans industry.
FAQ generated 2026-05-27

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms